Adding MGMT-modified gamma-delta T cells to temozolomide in models of high-grade gliomas Oct. 29, 2021 No Comments
Ec1-LoPE DARPin-toxin fusion protein evaluated with trastuzumab for ovarian cancer Oct. 27, 2021 No Comments
New CD80/PD-L1 and/or PD-1/PD-L1 interaction inhibitors discovered at Bristol Myers Squibb Oct. 26, 2021 No Comments
CS-5001, novel ADC with promising efficacy in models of ROR1-expressing cancers Oct. 26, 2021 No Comments
Regeneron ADC REGN3124-PBD prolongs survival in mice with intracranial glioblastoma tumors Oct. 22, 2021 No Comments
Nordic Nanovector and University of Pennsylvania establish CD37-targeting CAR-T cell collaboration Oct. 19, 2021 No Comments
CoImmune and MSK collaborate to adapt CAR-CIK technology to treat solid tumors Oct. 19, 2021 No Comments